Tyman - Termination of coverage
Edison Investment Research is terminating coverage on Brooge Energy (BROG), Tyman (TYMN), SymBio Pharmaceuticals (4582), Aspire Global (0EAZ),...
19 Views
Tyman - Successfully navigating market challenges
Tyman’s business model stood up well to some unprecedented FY21 supply chain challenges and earnings were slightly above our estimates, despite...
92 Views
Tyman - Regional variation in resilient markets
Residential markets remain firm and Tyman’s International division has been the star performer so far in H2. At the same time, supply chain...
773 Views
Tyman - More upgrades from ongoing trading momentum
A strong end to FY20 has fed into good momentum at the beginning of FY21 and all three divisions performed ahead of management’s expectations in...
344 Views
Tyman - Momentum accelerates in Q3
After COVID-19 affected Q2/H1 trading, recovering market conditions in Q3 led to Tyman achieving +3% like-for-like revenue growth in the quarter...
287 Views